NanoViricides
NNVC
36 hedge funds and large institutions have $3.01M invested in NanoViricides in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 5 closing their positions.
417% more call options, than puts
Call options by funds: $217K | Put options by funds: $42K
200% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 5
38% more funds holding
Funds holding: 26 → 36 (+10)
1.05% less ownership
Funds ownership: 8.4% → 7.35% (-1%)
47% less capital invested
Capital invested by funds: $5.7M → $3.01M (-$2.69M)
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$260K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$227K |
| 3 |
HIS
Harvest Investment Services
Oakbrook Terrace,
Illinois
|
+$117K |
| 4 |
Jane Street
New York
|
+$83.3K |
| 5 |
OPS
Orion Portfolio Solutions
Omaha,
Nebraska
|
+$77.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$528K |
| 2 |
Morgan Stanley
New York
|
-$138K |
| 3 |
Goldman Sachs
New York
|
-$82.4K |
| 4 |
VF
Virtu Financial
New York
|
-$79.3K |
| 5 |
BlackRock
New York
|
-$67.7K |
NNVC Hedge Fund Activity: Q3 2020 in Review
36 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2020, worth a combined $3.01M — down 47% from $5.7M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new NNVC positions and 5 closed out — a net gain of 10 holders — while 3 added to existing stakes and 8 trimmed.
The largest buyer was Wedbush Securities, opening a new position worth an estimated $260K. The largest seller was Bank of America, cutting an estimated $528K.
- 36 institutional investors held NanoViricides (NNVC) as of Q3 2020, up from 26 in Q2 2020.
- Funds reported $3.01M of NanoViricides stock for Q3 2020, down 47% quarter-over-quarter.
- 15 funds opened new NanoViricides positions in Q3 2020 and 5 closed out, a net change of +10 holders.
- The largest NanoViricides buyer in Q3 2020 was Wedbush Securities, an estimated $260K added.
- The largest NanoViricides seller in Q3 2020 was Bank of America, an estimated $528K sold.
Based on aggregated 13F filings for Q3 2020.